Aprogen Healthcare & Games Inc banner

Intrinsic Value

The intrinsic value of Aprogen Healthcare & Games Inc (109960) under the Base Case is 151.61 KRW per share. Compared with the current market price of 1 654 KRW, the stock appears Overvalued by 91% .

The intrinsic value is calculated using the DCF method. The model assumes revenue returns to growth: about 6% a year over the next five years, after falling about 1% a year over the last five years. If revenue grew at its five-year pace of -1%, the estimate would be about ₩45. The forecast years subtract value, so the estimate rests entirely on the years after 2031.

Do our valuations actually work? See backtest results .

Intrinsic Value
₩151.61
Overvaluation 91%
Intrinsic Value
Price ₩1 654
Alert me when Aprogen Healthcare & Games Inc is below its intrinsic value
Today ₩121.29 · 92.7% below the current price

Aprogen Healthcare & Games Inc is valued in line with its history. A premium of this size has been typical over the past 5 years.

Alternatives to Aprogen Healthcare & Games Inc

Fundamental Analysis

What Aprogen Healthcare & Games Does

Biotechnology Health Care

Aprogen Healthcare & Games Inc is a Korean company with two very different lines of business: game publishing and healthcare-related development. On the games side, it makes and publishes online and mobile games and earns money when players buy in-game items or when its titles generate publishing fees and other service revenue. On the healthcare side, it has been involved in biotech and medical projects tied to drug development and related technologies.

Headquarters
Korea KR
IPO date
Nov 13, 2009
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
Aprogen Healthcare & Games Inc

Wall St Price Targets

Capital Returns

Competitive Landscape

What is the Intrinsic Value of one Aprogen Healthcare & Games Inc stock?

The intrinsic value for Aprogen Healthcare & Games Inc (109960) under the Base Case is 151.61 KRW.

Is Aprogen Healthcare & Games Inc stock undervalued or overvalued?

Compared with the current market price of 1 654 KRW, the stock appears Overvalued by 91% .

Back to Top